COELHO PHILIP H 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Aug 19, 2022
Insider Transaction Report
Form 4
COELHO PHILIP H
Director
Transactions
- Exercise/Conversion
Common stock, par value $0.001 per share
2022-08-17$2.53/sh+40,000$101,200→ 279,553 total - Exercise/Conversion
Options to purchase common stock
2022-08-17−40,000→ 296,834 totalExercise: $2.53Exp: 2022-12-30→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]Options vested in two annual tranches beginning on December 30, 2015.